Pestle

Country/product Brief

Abstract

This study will focus on globalization strategy of an Indian pharmaceutical company. The purpose of the report is to analyze the market entry opportunity for an Indian pharmaceutical company in USA. Organization selected for the study is Lupin Ltd, which is an Indian MNC catering to more than 70 countries across the globe. The report will highlight the external business environment of USA and offer insights to entry opportunities for Lupin in USA. This study will also focus on the competition level in pharmaceutical market and future prospect for Lupin to establish itself in the USA market as a pharmaceutical giant.

Table of Contents

1.0 Introduction 4

1.1 Background 4

1.2 Purpose of the Report 4

2.0 Macro and Micro Environment 5

2.1 Political Factor 5

2.2 Economic Factor 6

2.3 Social Factor 6

2.4 Technological Factor 7

2.5 Environmental Factor 7

2.6 Legal Factor 8

3.0 Customer segments 8

4.0 Market entry opportunities & Barriers 9

4.1 Opportunities 9

4.2 Barriers 9

5.0 Channels of distribution 10

6.0 Competitive threats 10

7.0 Recommendations 11

8.0 Conclusion 11

9.0 References 12

1.0 Introduction

Global pharmaceutical market is valued at € 484,151million but more than 47% of the market share is dominated by USA alone. US pharmaceutical industry has discovered almost 370 different drugs in last decade. 50% of drugs are in the area of heart disease or hypertension, Alzheimer’s disease, arthritis, Parkinson’s, and Cancer. Some of the well known pharmaceutical companies of USA are Amgen, Pfizer, Marc, and Bristol-Myers Squibb among others (Economy Watch, 2010). The pharmaceutical market is highly competitive as a number of established pharmaceutical companies operate in USA. In the context of the study Lupin Limited, an Indian pharmaceutical giant has been chosen as the organization to conduct the study. The next half of the report will...